DispersinB Cleanser for Acne
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate the effectiveness and skin tolerance of DispersinB Acne Cleanser when used with Benzoyl Peroxide, a common acne treatment. Researchers will compare the effects on each side of the face to determine if adding DispersinB improves acne clearance. Individuals with mild to moderate acne and an even number of acne spots on both sides of their face may be suitable candidates for this study. As an unphased trial, this study provides a unique opportunity to contribute to the understanding of new acne treatment combinations.
Do I need to stop my current medications to join the trial?
Yes, you may need to stop certain medications before joining the trial. There are specific 'washout' periods (time without taking certain medications) for various treatments, such as 2 weeks for topical treatments and up to 12 weeks for some systemic treatments like oral retinoids.
What prior data suggests that the DispersinB Acne Cleanser is safe for treating acne?
Research has shown that DispersinB Acne Cleanser is under study to determine its effectiveness in improving acne treatment. One study found that DispersinB can enhance the efficacy of benzoyl peroxide, a common acne treatment, by making bacteria more susceptible. This combination might allow for lower doses of benzoyl peroxide, potentially reducing the risk of side effects.
Specific safety information about DispersinB Acne Cleanser in humans remains limited, as it is still under testing. However, since it is tested alongside benzoyl peroxide, which is widely used and generally safe for most people, there is some confidence in its safety. Benzoyl peroxide can sometimes cause mild skin irritation, such as redness or dryness, but these effects are usually manageable.
The trial is in an early stage, focusing on testing the concept and assessing tolerance. Researchers are still gathering safety information, so participants must report any side effects they experience.12345Why are researchers excited about this trial?
DispersinB Acne Cleanser is unique because it targets acne by disrupting biofilms, which are protective layers that bacteria form on the skin. Most standard acne treatments, like topical antibiotics and benzoyl peroxide, focus on killing bacteria or reducing inflammation. However, DispersinB takes a different approach by breaking down these biofilms, potentially making it easier to clear acne-causing bacteria. This distinct mechanism could lead to more effective treatment outcomes and is why researchers are excited about its potential.
What evidence suggests that DispersinB Acne Cleanser might be an effective treatment for acne?
Research has shown that DispersinB Acne Cleanser can greatly reduce the bacteria that cause acne. In this trial, participants will apply DispersinB to one side of the face and a 4% benzoyl peroxide facial wash to the entire face for a split-face comparison. Previous studies have demonstrated that combining DispersinB with benzoyl peroxide reduces acne bacteria more effectively than using DispersinB alone. This combination significantly decreases the bacteria responsible for acne. The treatment works well with benzoyl peroxide, a common acne treatment, suggesting it could help clear skin more effectively. These findings support the idea that DispersinB Acne Cleanser may be effective in treating acne.16789
Who Is on the Research Team?
Prinicipal Investigator
Principal Investigator
University of Miami
Are You a Good Fit for This Trial?
This trial is for adults with mild to moderate acne vulgaris. Participants will treat one side of their face with DispersinB Acne Cleanser and the other side with a standard treatment, allowing researchers to compare results directly on each person.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants apply DispersinB Acne Cleanser and 4% Benzoyl Peroxide for a split-face comparison over a 12-week period
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- DispersinB Acne Cleanser
Trial Overview
The study tests if DispersinB Acne Cleanser can improve acne when used alongside Benzoyl Peroxide compared to using Benzoyl Peroxide alone. It's an intra-individual comparison over 12 weeks, focusing on how many people achieve clear skin and the change in number of acne lesions.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Subjects will complete baseline assessments and be randomized (left face versus right face) to apply DispersinB Acne Cleanser over at 12-week treatment period, for an intra-individual, split-face comparison. Subjects will use the DispersinB Acne Cleanser on the assigned facial side for 5 minutes and then will use the provided 4% Benzoyl peroxide facial wash to wash entire face for daily (evening) use.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kane Biotech Inc
Lead Sponsor
University of Miami
Collaborator
Citations
Efficacy and Tolerability of DispersinB Acne Cleanser in ...
This is a single-center study using intra-individual comparison (right half-face versus left half-face) to evaluate the efficacy and tolerability of DispersinB ...
Synergistic activity of dispersin B and benzoyl peroxide ...
Dispersin B or BP alone reduced C. acnes colony-forming units (CFUs) by 1-2 log units. However, sequential treatment with dispersin B followed ...
Kane Biotech's New Acne Treatment Study: What Investors ...
' The study aims to evaluate the effectiveness and tolerability of DispersinB Acne Cleanser in treating facial acne. The primary objectives include assessing ...
Kane Biotech Secures IRB Approval to Launch Innovative ...
The title of the study is “Split-face efficacy and tolerability of DispersinB® Acne Cleanser in the treatment of mild to moderate Acne Vulgaris.
5.
theglobeandmail.com
theglobeandmail.com/investing/markets/markets-news/GetNews/34269800/acne-vulgaris-market-outlook-2034-clinical-trials-market-size-medication-prevalence-companies-by-delveinsight/Acne Vulgaris Market Outlook 2034 – Clinical Trials, Market Size, ...
In April 2025, Dermata reported Phase III results showing XYNGARI achieved significant efficacy, separating from placebo after four weekly treatments, ...
Synergistic activity of dispersin B and benzoyl peroxide ...
This study evaluated the efficacy of the PNAG-degrading enzyme dispersin B in enhancing the susceptibility of C. acnes biofilms to benzoyl peroxide (BP), a ...
Synergistic activity of dispersin B and benzoyl peroxide ...
The use of dispersin B in combination with BP could therefore be a promising strategy for acne treatment and prevention, as it may reduce the minimum effective ...
KSL-W Peptide-Based Wound Gel Against Chronic ...
As the conventional treatment modalities have proven ineffective, this study provides the in vitro evidence to support the use of a novel ...
GREEN BOOK 1 Triclosan CIR EXPERT PANEL MEETING ...
One study was cited by the European Commission in their analysis of public input on their 2009 opinion on triclosan safety that was not listed ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.